Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Covid-19 Mortality in Patients With Immunodeficiency and Its Predictors: A Systematic Review Publisher Pubmed



Seyedalinaghi SA1 ; Karimi A2 ; Barzegary A3 ; Mojdeganlou H4 ; Vahedi F2 ; Mirghaderi SP2 ; Shobeiri P2 ; Ramezani M5 ; Yousefi Konjdar P6 ; Mirzapour P1 ; Tantuoyir MM2, 7 ; Mehraeen E8 ; Dadras O9 ; Voltarelli F10
Authors

Source: European Journal of Medical Research Published:2022


Abstract

Introduction: Patients with immunodeficiency are usually more prone to worse outcomes of infectious diseases. However, there are some disagreements in the context of COVID-19, for example, in patients with human immunodeficiency virus (HIV). Herein, we aimed to systematically review the risk and predictors of COVID-19 mortality in people with primary or secondary immunodeficiency. Methods: PubMed, Scopus, Web of Science, and Science Direct were searched. We followed a two-step screening process to identify eligible results. We first reviewed the title and abstract of the records and the unqualified studies were removed. Then, their full texts were evaluated based on their coherence with the purpose and inclusion/exclusion criteria, and those eligible for qualitative synthesis were included. Results: Twenty-two articles were included, which investigated a total of 109,326 with primary or secondary immunodeficiencies. Three studies investigated the pediatric and infant population, while other studies were conducted on the adult population. Overall, studies on both primary and secondary immunodeficiency conflicted as some reported higher and some mentioned lower mortality rates in patients with immunodeficiency. Conclusions: Overall, there were two points of view in both types of immunodeficiencies. The first is the classical viewpoint that all immunodeficient patients are at a higher risk of infection leading to a higher mortality rate. The second types of studies found that immunodeficiency might play a less important or even an inverse role in mortality rates by lowering the severity of the inflammatory response. However, it is important to take note to comorbidities, such as DM, HTN, CAD, ESRD, history of lower respiratory infection, etc., and demographic factors, such as obesity and age > 70 years, as they appear to influence the mortality rate, especially in patients with secondary immunodeficiency. © 2022, The Author(s).
Other Related Docs
5. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
6. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)